Cargando…
Eltrombopag inhibits the proliferation of Ewing sarcoma cells via iron chelation and impaired DNA replication
BACKGROUND: The treatment of Ewing sarcoma, an aggressive bone and soft tissue sarcoma, is associated with suboptimal outcomes and significant side-effects. Consequently, there is an urgent need to identify novel therapies that will improve outcomes for children and adults with Ewing sarcoma tumors...
Autores principales: | Waters, Torin, Goss, Kelli L., Koppenhafer, Stacia L., Terry, William W., Gordon, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706234/ https://www.ncbi.nlm.nih.gov/pubmed/33256675 http://dx.doi.org/10.1186/s12885-020-07668-6 |
Ejemplares similares
-
The translational repressor 4E-BP1regulates RRM2 levels and functions as a tumor suppressor in Ewing Sarcoma Tumors
por: Goss, Kelli L., et al.
Publicado: (2020) -
Activator Protein-1 (AP-1) Signaling Inhibits the Growth of Ewing Sarcoma Cells in Response to DNA Replication Stress
por: Croushore, Emma E., et al.
Publicado: (2023) -
Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine
por: Goss, Kelli L, et al.
Publicado: (2017) -
Inhibitor of DNA Binding 2 (ID2) Regulates the Expression of Developmental Genes and Tumorigenesis in Ewing Sarcoma
por: Koppenhafer, Stacia L., et al.
Publicado: (2022) -
The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation
por: Vogel, Jens-Uwe, et al.
Publicado: (2019)